News

2022 Sep 26

A New Tool for Discovering Cancer-Driving Structural Variations

An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers. In the study , published Sept. 26 in Nature... Read more

2022 Sep 22

Study Illuminates Precancerous "Clonal Outgrowth" in Blood Cells

A common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may promote these diseases by altering the stem cells’ programming of gene activity and... Read more

2022 Sep 19

Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their... Read more

2022 Sep 14

New MCC Deputy Director Dr. Taha Merghoub Discusses His Passion for Cancer Research and Shares What It Means to “Push Boundaries” as a Scientist

There is no single event that inspired Dr. Taha Merghoub’s journey from his childhood in the Sahara Desert to his recent appointment as deputy director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine... Read more

2022 Sep 13

USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease

Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a... Read more

2022 Sep 01

Department of Defense Awards Weill Cornell Medicine New Grant for Kidney Cancer Research

Weill Cornell Medicine has been awarded a $1 million, three-year grant from the Department of Defense’s Kidney Cancer Research Program to fund research on the role of the protein ATF4 in clear cell renal cell carcinoma (... Read more

progressively zoomed in image of thymic cancer

2022 Aug 29

New Preclinical Model Could Accelerate Research on Thymic Cancer

A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed... Read more

2022 Aug 19

Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders

When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that trips these defenses, a discovery that helps to explain the... Read more

2022 Aug 17

Portable Cancer Testing Expands in Sub-Saharan Africa

This article by David Nutt first appeared in the Cornell Chronicle. A portable diagnostic device designed by researchers at Cornell Engineering and Weill Cornell Medicine has been deployed in clinical tests in Uganda to... Read more

2022 Jul 28

Dr. Jedd Wolchok Appointed Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine

NEW YORK (July 28, 2022) — Dr. Jedd Wolchok , an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra... Read more

2022 Jun 30

In Brief: Surgery May be Avoided for Children with Rare Skull Tumor

Surgery can usually be avoided in children with a rare tumor of the skull, based on new research by investigators from Weill Cornell Medicine , NewYork-Presbyterian , Nicklaus Children’s Hospital , the University of Texas... Read more

2022 Jun 29

Weill Cornell Medicine Receives Cancer Grand Challenges Award Focused on Cachexia

Weill Cornell Medicine, Rutgers Cancer Institute of New Jersey and Cold Spring Harbor Laboratory have received a $25 million Cancer Grand Challenges award to tackle cancer cachexia, the debilitating wasting syndrome that is... Read more

Cancer cells, malignant cells, scientific 3D illustration

2022 Jun 29

In Brief: Treating Precancerous Anal Lesions Reduces Anal Cancer Risk by More Than Half in People with HIV

A large clinical trial among people living with HIV has found that treating anal precancerous lesions cuts the risk of developing anal cancer by 57 percent compared with active monitoring with no treatment. The ANCHOR study... Read more

closeup of doctor's hand writing in chart

2022 Jun 28

Mantle Cell Lymphoma Treatment Varies According to Setting

There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators... Read more

2022 Jun 23

New Technology Helps Reveal Inner Workings of Human Genome

Weill Cornell Medicine and New York Genome Center researchers, in collaboration with Oxford Nanopore Technologies, have developed a new method to assess on a large scale the three-dimensional structure of the human genome,... Read more

2022 Jun 09

Cancer symposium fosters collaboration across Cornell

On May 19 and 20, researchers from Cornell University’s Ithaca and New York City campuses gathered at the Cornell College of Veterinary Medicine (CVM) for the third Intercampus Cancer Research Symposium. Returning after a... Read more

a woman in a white coat posing for a photo

2022 Jun 06

Dr. Sara Zaccara Honored with 2022 Tri-Institutional Breakout Award

Dr. Sara Zaccara, a postdoctoral associate in the Department of Pharmacology at Weill Cornell Medicine, has won a 2022 Tri-Institutional Breakout Award for Junior Investigators. Weill Cornell Medicine, Memorial Sloan... Read more

2022 Jun 03

2022 Biomedical Business Plan Challenge Showcases Promising Startups

A promising venture that hopes to develop a new drug therapy for colorectal cancer won $50,000 in funding and recognition from experienced venture capitalists on May 26 at the annual Biomedical Business Plan Challenge. The... Read more

3D rendering of a NK Cell (Natural Killer Cell) destroying a cancer cell

2022 Jun 02

Immune Therapy Targets Cells that Cause Leukemia Relapse

Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia (AML), a type of blood cancer, and proved effective in animal models of the... Read more

2022 May 31

Awards and Honors – May 31, 2022

Dr. Joseph J. Fins , chief of the Division of Medical Ethics, the E. William Davis Jr., M.D., Professor of Medical Ethics and a professor of medicine, was honored as an Honorary Doctor of Humane Letters at Wesleyan... Read more